Programme Invest In Biomed

Invest in Biomed's 2025 promotion is launched!

This unique program supports selected startups to allow them to properly structure their fundraising and meet investors specializing in their sector.

The advantages enjoyed by Invest in Biomed 2025 startups

  • Guide their communication in order to convince investors
  • Obtain Personalized feedback on their pitch decks, on the background and form, by experienced professionals in health fundraising
  • Be coached on their oral service
  • Present their project in front of a panel of investors specialized in their fields
  • Establish or consolidate links with these investors and obtain their qualitative feedback on their project

Le programme Invest In Biomed

6 workshops collective or individual March to June 2025, led by experts in health and fundraising

Flash review of your project

A 360° analysis of your project, based on a deck review and two interviews

Speakers: experts de l'équipe Eurobiomed

Understand investors’ expectations and their investment methods

Speakers: Health VCs

Work on your equity story and the deck

Speakers: health fundraising experts

Work on your oral performance

Speaker: consultant en communication

A day of pitching and meetings with investors

Pitches from project leaders and investors
BtoB meeting session

Prepare the next steps of your lifting

Debrief of investor meetings
Preparing for the next steps in your lifting

Speakers: experts de l'équipe Eurobiomed

Discover the testimonies of 4 startups accompanied by Invest in Biomed

A look back at the 2024 edition

The health fundraising experts of the class of 2024

  • Sofia ARNAL – AdBio Partners Associate, pharmacist by training
  • Sophie BRAUN – Health consultant In Extenso Croissance
  • Karine CHORRO – Phost’In Therapeutics, CEO et co-fondatrice, ex deputy director Genepep
  • Stéphane DEBONO – Former Deputy CEO and VP of HalioDx
  • Vincent FERT – Partner Turenne Groupe, former CEO/President HalioDx
  • Pierre HORNUS – CEO/Co-founder Semeia
  • Francine LANCELEUR BRENNING – Director Qualitalents, former General Manager/BD MediHandTrace
  • Laure Hélène MERCIER – LH Mercier Conseil, consultant in fund raising, IPO, ex CFO Innate Pharma
  • Claire NAUSSAC – Operating partner Truffle Capital
  • Claire VERSCHELDE – ICOSA, Co-founding Partner, specialized in IP
  • Grégory VOISIN – CEO and founder ToxiPlan

Investors of the class of 2024

Program partners

Our financiers

For more
information

Contact us!

J
No results found.